Helsinki (Reuters) - Finland's Orion (HE:ORNBV) on Friday upgraded its 2020 operating profit outlook, saying the coronavirus pandemic had caused asignificant increase in demand for its drugs in the first quarter.
"Orion estimates the full-year 2020 operating profit to be higher than previously estimated due to the strong start of the year," the company said in a statement.
European sales of certain proprietary products were also expected to exceed previously estimated levels, it said.